BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11541510)

  • 1. Clinical utility of T-wave alternans.
    Armoundas AA; Cohen RJ
    Card Electrophysiol Rev; 1997; 1(3):390-4. PubMed ID: 11541510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T wave alternans: a marker of myocardial instability.
    Harvey M; Malkin R
    Prog Cardiovasc Nurs; 2003; 18(2):99-107, 111. PubMed ID: 12732803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ambulatory ECG-based T-wave alternans monitoring for risk assessment and guiding medical therapy: mechanisms and clinical applications.
    Verrier RL; Ikeda T
    Prog Cardiovasc Dis; 2013; 56(2):172-85. PubMed ID: 24215749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-wave alternans and the susceptibility to ventricular arrhythmias.
    Narayan SM
    J Am Coll Cardiol; 2006 Jan; 47(2):269-81. PubMed ID: 16412847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification.
    Gold MR; Bloomfield DM; Anderson KP; El-Sherif NE; Wilber DJ; Groh WJ; Estes NA; Kaufman ES; Greenberg ML; Rosenbaum DS
    J Am Coll Cardiol; 2000 Dec; 36(7):2247-53. PubMed ID: 11127468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrical alternans and vulnerability to ventricular arrhythmias.
    Rosenbaum DS; Jackson LE; Smith JM; Garan H; Ruskin JN; Cohen RJ
    N Engl J Med; 1994 Jan; 330(4):235-41. PubMed ID: 8272084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T wave alternans as a predictor of recurrent ventricular tachyarrhythmias in ICD recipients: prospective comparison with conventional risk markers.
    Hohnloser SH; Klingenheben T; Li YG; Zabel M; Peetermans J; Cohen RJ
    J Cardiovasc Electrophysiol; 1998 Dec; 9(12):1258-68. PubMed ID: 9869525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and ionic basis for T-wave alternans under long-QT conditions.
    Shimizu W; Antzelevitch C
    Circulation; 1999 Mar; 99(11):1499-507. PubMed ID: 10086976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microvolt level T wave alternans: a new marker for noninvasive risk stratification].
    Klingenheben T; Credner S; Li YG; Bender B; Hohnloser SH
    Z Kardiol; 2000; 89 Suppl 3():57-61. PubMed ID: 10810786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias.
    Estes NA; Michaud G; Zipes DP; El-Sherif N; Venditti FJ; Rosenbaum DS; Albrecht P; Wang PJ; Cohen RJ
    Am J Cardiol; 1997 Nov; 80(10):1314-8. PubMed ID: 9388105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-wave alternans, restitution of human action potential duration, and outcome.
    Narayan SM; Franz MR; Lalani G; Kim J; Sastry A
    J Am Coll Cardiol; 2007 Dec; 50(25):2385-92. PubMed ID: 18154963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heterogeneities of ventricular repolarization and vulnerability to arrhythmia. How to detect them with noninvasive methods?].
    De Ambroggi L
    Cardiologia; 1999 Apr; 44(4):355-60. PubMed ID: 10371787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
    Antzelevitch C; Yan GX; Shimizu W
    J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenesis of T wave alternans associated with surface QRS complex alternans and the role of ventricular prematurity: observations from a canine model of LQT3 syndrome.
    Chinushi M; Hosaka Y; Washizuka T; Furushima H; Aizawa Y
    J Cardiovasc Electrophysiol; 2002 Jun; 13(6):599-604. PubMed ID: 12108505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the estimation of T-wave alternans using the spectral fast fourier transform method.
    Armoundas AA; Mela T; Merchant FM
    Heart Rhythm; 2012 Mar; 9(3):449-56. PubMed ID: 22001706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death.
    Tse G; Yan BP
    Europace; 2017 May; 19(5):712-721. PubMed ID: 27702850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo.
    Nieminen T; Scirica BM; Pegler JR; Tavares C; Pagotto VP; Kanas AF; Sobrado MF; Nearing BD; Umez-Eronini AA; Morrow DA; Belardinelli L; Verrier RL
    Am J Cardiol; 2014 Jul; 114(1):17-23. PubMed ID: 24852915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A translational approach to probe the proarrhythmic potential of cardiac alternans: a reversible overture to arrhythmogenesis?
    Merchant FM; Sayadi O; Puppala D; Moazzami K; Heller V; Armoundas AA
    Am J Physiol Heart Circ Physiol; 2014 Feb; 306(4):H465-74. PubMed ID: 24322612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repolarization alternans: implications for the mechanism and prevention of sudden cardiac death.
    Walker ML; Rosenbaum DS
    Cardiovasc Res; 2003 Mar; 57(3):599-614. PubMed ID: 12618222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic conduction and repolarization markers associated with sudden cardiac death: moving along the electrocardiography waveform.
    Reynard JT; Oshodi OM; Lai JC; Lai RW; Bazoukis G; Fragakis N; Letsas KP; Korantzopoulos P; Liu FZ; Liu T; Xia Y; Tse G; Li CK
    Minerva Cardioangiol; 2019 Apr; 67(2):131-144. PubMed ID: 30260143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.